Merck, Plaintiffs Fail To Reach Deal In Fosamax Jaw MDL

Law360, New York (August 15, 2013, 7:24 PM EDT) -- Merck & Co. Inc. and a group of plaintiffs in multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax broke off settlement talks on Wednesday, a day after a judge peppered the drugmaker with questions about why it has not yet resolved the litigation.

A mediation session between Merck and attorneys from Levin Papantonio Thomas Mitchell Rafferty & Proctor PA and Ashcraft & Gerel LLP, who were negotiating on behalf of plaintiffs in approximately 370 cases in the litigation, ended in an impasse,...
To view the full article, register now.